Catalogo dei prodotti della ricerca

FERRO, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.610
EU - Europa 1.552
AS - Asia 882
SA - Sud America 81
AF - Africa 22
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.150
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.586
IT - Italia 505
SG - Singapore 460
IN - India 198
SE - Svezia 186
UA - Ucraina 165
CN - Cina 160
DE - Germania 157
FI - Finlandia 152
RU - Federazione Russa 89
RO - Romania 84
GB - Regno Unito 68
BR - Brasile 53
AT - Austria 38
JO - Giordania 24
BG - Bulgaria 23
IE - Irlanda 23
AR - Argentina 22
CA - Canada 18
BE - Belgio 14
FR - Francia 14
ID - Indonesia 13
TG - Togo 11
NL - Olanda 8
GR - Grecia 5
EG - Egitto 4
HK - Hong Kong 4
PL - Polonia 4
CH - Svizzera 3
CL - Cile 3
MX - Messico 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 3
TR - Turchia 3
VN - Vietnam 3
AU - Australia 2
BJ - Benin 2
BY - Bielorussia 2
EC - Ecuador 2
IQ - Iraq 2
IR - Iran 2
KR - Corea 2
LU - Lussemburgo 2
PA - Panama 2
PK - Pakistan 2
AL - Albania 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ES - Italia 1
EU - Europa 1
HU - Ungheria 1
JP - Giappone 1
KE - Kenya 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
PY - Paraguay 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 7.150
Salva come PNG Salva come JPEG
Città #
Fairfield 773
Woodbridge 427
Houston 321
Chandler 306
Ashburn 294
Seattle 263
Ann Arbor 258
Cambridge 231
Wilmington 219
Singapore 212
Rome 180
Princeton 116
Santa Clara 114
Dearborn 113
Munich 97
San Paolo di Civitate 96
Plano 91
Lawrence 84
Fremont 81
Beijing 80
Horia 70
San Diego 69
Jacksonville 67
Helsinki 59
Boston 53
Millbury 47
Andover 33
Vienna 31
Cosenza 28
Southend 27
Boardman 23
Dublin 23
Sofia 23
New York 21
Des Moines 20
Federal 20
Amman 19
Norwalk 19
Milan 18
Moscow 16
Brussels 14
Bremen 13
Jakarta 13
Toronto 13
Falls Church 11
Lomé 11
Yubileyny 11
London 10
Bologna 9
Dallas 9
Falkenstein 9
Hefei 9
Nuremberg 9
Pomezia 9
San Mateo 9
Nanjing 8
Los Angeles 6
Redwood City 6
Buffalo 5
Bühl 5
Guangzhou 5
Hebei 5
Jyväskylä 5
Kunming 5
São Paulo 5
Zarqa 5
Birmingham 4
Cairo 4
Cascina 4
Council Bluffs 4
Hong Kong 4
Mannheim 4
Palermo 4
Sacramento 4
San Jose 4
Baotou 3
Belo Horizonte 3
Betim 3
Chieti 3
Florence 3
Istanbul 3
Meda 3
Phoenix 3
Tappahannock 3
Torino 3
Trumbull 3
Auburn Hills 2
Baghdad 2
Berlin 2
Bern 2
Bolzano Vicentino 2
Brasília 2
Bulgarograsso 2
Campinas 2
Chengdu 2
Chongqing 2
Duncan 2
Fasano 2
Fiumicino 2
Frankfurt am Main 2
Totale 5.358
Salva come PNG Salva come JPEG
Nome #
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study 228
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 177
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation. the ARAPACIS study 175
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia 153
Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia 137
Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation 134
LUPUS ANTICOAGULANT AND THE FIBRINOLYTIC SYSTEM IN YOUNG-PATIENTS WITH STROKE 127
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19). Relationship with mortality 111
Association between high values of D-dimer and Tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients 108
Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. 104
Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation 103
Hemostatic balance in patients with liver cirrhosis. report of a consensus conference 101
HYPERFIBRINOLYSIS INCREASES THE RISK OF GASTROINTESTINAL HEMORRHAGE IN PATIENTS WITH ADVANCED CIRRHOSIS 99
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study 98
Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study 98
Ongoing prothrombotic state in the portal circulation of cirrhotic patients 91
Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies 90
Soluble CD154 plasma levels in patients with systemic lupus erythematosus: Modulation by antiphospholipid antibodies 89
Clotting activation after transjugular intrahepatic portosystemic stent shunt 88
1-YEAR SURVEY OF PATIENTS WITH ADVANCED LIVER-CIRRHOSIS - PROGNOSTIC VALUE OF CLINICAL AND LABORATORY INDEXES IDENTIFIED BY THE COX REGRESSION-MODEL 86
Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking Vitamin K antagonists 85
Clotting Activation and Hyperfibrinolysis in Cirrhosis: Implication for Bleeding and Thrombosis 83
Inhibition of tissue-factor-mediated thrombin generation by simvastatin 81
A POTENT CHAIN-BREAKING ANTIOXIDANT ACTIVITY OF THE CARDIOVASCULAR DRUG DIPYRIDAMOLE 81
Bleeding and thrombosis in cirrhotic patients: What really matters? 80
Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation 80
Determinants of enhanced thromboxane biosynthesis in systemic lupus erythematosus. 79
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy 79
ANTICOAGULANT ACTIVITY OF ANTICARDIOLIPIN ANTIBODIES 79
Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosis 79
Added fructose in non-alcoholic fatty liver disease and in metabolic sindrome. a narrative review 78
Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment 77
THROMBOSIS IN THE ANTIPHOSPHOLIPID-ANTIBODY SYNDROME 77
Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis 76
gp91phox-dependent expression of platelet CD40 ligand 76
Chocolate enriched by extra virgin olive oil improves endothelial function and oxidative stress in patients with diabetes 76
Coexistence of anti-phospholipid antibodies and endothelial perturbation in systemic lupus erythematosus patients with ongoing prothrombotic state 75
Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis. 74
PREKALLIKREIN AND FACTOR-VII AS PROGNOSTIC INDEXES OF LIVER-FAILURE 73
INHIBITION OF TISSUE PLASMINOGEN-ACTIVATOR INHIBITOR BY DEFIBROTIDE IN ATHEROSCLEROTIC PATIENTS 73
Sex-related differences in the association between metabolic syndrome and gallstone disease 73
Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia 72
Antiangiogenic metronomic Chemotherapy and hyperthermia in palliation of advanced cancer. 71
Author reply to comment on "Bleeding and thrombosis in cirrhotic patients: What really matters?" 71
CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia 70
Hepatitis C virus, antiphospholipid antibodies, and thrombosis 69
Prevalenced of portal vein thrombosis (PVT) and associated factors in cirrhotic patients 69
Poor adherence to mediterranean diet and serum lipopolysaccharide are associated with oxidative stress in patients with non-alcoholic fatty liver disease 69
High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: Relationship to endotoxemia 69
Increased thrombin generation and circulating levels of tumour necrosis factor-α in patients with chronic Helicobacter pylori-positive gastritis 68
Serum Levels of Vitamin E Are Associated With Early Recurrence of Atrial Fibrillation After Electric Cardioversion 67
LUPUS ANTICOAGULANT IN LIVER-CIRRHOSIS 67
LIPOPROTEIN (A) AND FIBRINOLYTIC SYSTEM IN LIVER-CIRRHOSIS 66
Enhanced expression of monocyte tissue factor in patients with liver cirrhosis 66
New insights into the pathogenesis of non-alcoholic fatty liver disease: gut-derived lipopolysaccharides and oxidative stress 66
Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia 65
LIPOPROTEIN (A) DOES NOT INFLUENCE HYPERFIBRINOLYSIS IN PATIENTS WITH LIVER-CIRRHOSIS 65
Low-grade endotoxemia and thrombosis in COVID-19 64
Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failure 63
Endotoxaemia, hyperfibrinolysis, and bleeding in cirrhosis 63
Evidence for anticoagulant activity and beta2-GPI accumulation in late endosomes of endothelial cells induced by anti-LBPA antibodies. 63
CLOTTING ABNORMALITIES IN CHRONIC LIVER-DISEASE 63
Ongoing prothrombotic state in patients with antiphospholipid antibodies: A role for increased lipid peroxidation 61
Enhanced soluble Cd40l as predictor of vascular events in patients with non-valvular atrial fibrillation: Results of a prospective study 60
Antioxidant treatment decreases the titer of circulating anticardiolipin antibodies 60
Specificity and sensitivity of diluted aPTT and anticardiolipin antibodies towards thrombosis and miscarriages in patients with systemic lupus erythematosus 60
Fibrinolytic balance and lupus anticoagulant in patients with repeated fetal loss 59
PREVALENCE OF LUPUS ANTICOAGULANT IN PATIENTS WITH CIRRHOSIS - RELATIONSHIP WITH BETA-2-GLYCOPROTEIN-I PLASMA-LEVELS 59
PREVALENCE OF HYPERFIBRINOLYSIS IN PATIENTS WITH LIVER-CIRRHOSIS 58
Increased thromboxane metabolites excretion in liver cirrhosis 58
Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients 58
Cholesterol remnants, triglyceride-rich lipoproteins and cardiovascular risk 58
INTERRELATION BETWEEN FACTOR-VII, PREKALLIKREIN, AND HYPERFIBRINOLYSIS IN ADVANCED CIRRHOSIS 57
Premature coronary disease in systemic lupus 56
Alpha-linolenic acid-rich wheat germ oil decreases oxidative stress and CD40 ligand in patients with wild hypercholesterolemia 55
Coagulopathy of Chronic Liver Disease 54
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? 54
ARE LOW-LEVEL OF HDL2-CHOLESTEROL A RISK FACTOR FOR ATHEROSCLEROSIS OF CEREBRAL VASCULAR-DISEASE - CASE-REPORT 54
Statins as Antithrombotic Drugs 53
EVALUATION OF D-DIMER IN PATIENTS WITH LIVER-CIRRHOSIS 52
Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. CALC Group. 52
Diet and metabolic syndrome. A narrative review 51
Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis 51
Vitamin E reduces monocyte tissue factor expression in cirrhotic patients 49
Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis. 48
EFFECT OF ORAL DEFIBROTIDE ON TISSUE-PLASMINOGEN ACTIVATOR AND TISSUE-PLASMINOGEN ACTIVATOR INHIBITOR BALANCE 47
SUCCESSFUL REMOVAL OF ANTIPHOSPHOLIPID ANTIBODIES USING REPEATED PLASMA EXCHANGES AND PREDNISONE 45
Lupus anticoagulant and increased thrombin generation in patients with systemic lupus erythematosus. 44
Enhanced lipid peroxidation in hepatic cirrhosis 44
Hyperfibrinolysis in liver disease. 2009 Feb;13(1):21-31. 44
Enhanced soluble CD40L in patients with the metabolic syndrome: relationship with in vivo thrombin generation 42
Association between prolonged bleeding time and gastrointestinal hemorrhage in 102 patients with liver cirrhosis: results of a retrospective study. 42
INTRAVASCULAR CLOTTING ACTIVATION AND SYSTEMIC HYPERFIBRINOLYSIS IN PATIENTS WITH SEVERE LIVER-CIRRHOSIS - THE ROLE OF ASCITES 41
Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease 39
Ongoing prothrombotic state in patients with antiphospholipid antibodies: A role for increased lipid peroxidation 38
Anticardiolipin antibodies possess anticoagulant activity which is blocked by a monoclonal antibody against a cross reacting idiotype of antiphospholipid antibodies 35
Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelia procoagulant activation 32
Methods for detecting lupus anticoagulant and their relationship to thrombosisand miscarriage in patients with systemic lupus erythematosus 30
Open issues in the transition from nafld to mafld. the experience of the plinio study 29
Relationship between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver 29
Totale 7.295
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.303
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020375 0 0 0 0 0 0 0 0 156 106 75 38
2020/2021768 60 49 27 125 13 103 8 45 61 184 66 27
2021/20221.181 9 77 126 48 129 54 48 110 77 97 189 217
2022/20231.164 236 280 65 126 120 114 8 60 86 16 32 21
2023/2024467 46 55 21 32 29 44 23 27 5 73 51 61
2024/20251.049 42 68 67 79 113 98 145 106 331 0 0 0
Totale 7.411